Innovation X Healthcare = Empower ESRD Patients A Better Life
創新x醫療=腎利透析生活
Baxter Healthcare Ltd.
INTRODUCTION
To raise awareness of CKD and improve ESRD patients’ life quality in Taiwan, the Company has been operating for over 40 years to leverage on the engagement with key stakeholders including PD Patient Association, patients and HCPs to find out and meet the unmet needs of dialysis treatment in Taiwan . Baxter is one of the largest suppliers of PD therapy which supports patients to decide their lifestyle and make the best of their lives. The Company is aligned with government’s policy to increase awareness of Shared Decision Making (SDM) and effectively improving the quality of healthcare in Taiwan. Over the years, the Company has proved that ESRD patients can live the life they want, and reverse their image of sick people as the burden of the society.
FRAMEWORK AND STRATEGY
Baxter has improved patient’s experience with digital approach by developing the SDM system and promoting Claria with sharesource to build up patient’s confidence in home dialysis with remote patient management . The ability to automatically track treatment data for multiple patients can potentially increase efficiency by allowing to prioritise clinic resources and to empower patient to have comprehensive Peritoneal Dialysis (PD) knowledge. Baxter employees are strongly encouraged to contribute their skills and expertise such as nurse training, volunteering activities to support the local patient community. The Company also collaborates with patient group to develop educational animation, booklet of Renal Therapy replacement therapy. During this pandemic, it is crucial to receive kidney dialysis at home, the need to visit hospitals can be significantly reduced and in turn prevents the risk of COVID-19 infection and improves the quality of life for patients.ACHIEVEMENT AND IMPACT
This programme supports a more proactive way of managing patients’ care. With the improved visibility to patient adherence, the clinician can personalise the care of their patients by better understanding how patients’ symptoms are understood via data. Additionally, three patient stories in microfilm way went viral and gained 400,000 views and interactions on social media. Among patient supporting, Baxter took the crucial role to liaise patient groups and medical societies in Taiwan to synergise the energy to support patients. Innovative educational content including e-SDM system and educational animation were integrated in 80% Taiwan hospitals providing PD caring. For patient that chose PD, Baxter invigorates caring momentum like dialysate home delivery without charge.FUTURE DIRECTION
Baxter’s dedication to Dialysis Therapy for ESRD Patients by using data-driven insights to transform care through increased efficacy, improved safety, better decision making and enhanced patient experience. Sharesource is a revolutionary connectivity platform to transform how HCPs providing dialysis, allowing them to connect with their patients even beyond the routine clinic visits. With on-demand access to current and historical treatment data, Sharesource can help HCPs to be informed therapeutic recording to make precise and suitable clinical decisions for patients. The future direction of the Company is to continue to improve patient compliance, to resolve any issues with patient treatments, while increasing clinic efficiency by reducing time spent on transcribing patient logs during clinic visits. Lastly, to implement a simplistic design by providing modern patient devices and this is seen in Sharesource which utilises cloudbased technology.
Every day, millions of patients and caregivers rely on Baxter’s
leading portfolio of critical care, nutrition, renal, hospital and surgical
products. For more than 85 years, the Company has been operating
at the critical intersection where innovations that save and sustain
lives meet the healthcare providers that make it happen. With
products, technologies and therapies available in more than 100
countries, Baxter’s employees worldwide are now building upon
the Company’s rich heritage of medical breakthroughs to advance
the next generation of transformative healthcare innovations.
